Results 231 to 240 of about 124,517 (353)
ABSTRACT Elafibranor 80 mg/day is approved for second‐line primary biliary cholangitis (PBC) treatment. We present pharmacokinetic (PK) analyses of elafibranor and its metabolite, GFT1007, and pharmacokinetic‐pharmacodynamic (PKPD) analyses describing the relationship between their exposure and responses in alkaline phosphatase (ALP) and total ...
Qing Xi Ooi +5 more
wiley +1 more source
Clinicopathological features of non-cirrhotic portal fibrosis in primary biliary cholangitis: a 15-year experience at a tertiary referral center. [PDF]
Wang X +5 more
europepmc +1 more source
ABSTRACT Background Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.
M. Iborra +51 more
wiley +1 more source
Clinical outcomes in Caroli disease and Caroli syndrome: a longitudinal observational cohort study. [PDF]
Hanafy AS +7 more
europepmc +1 more source
Late com plications with gallbladder conduit biliary reconstruction after liver transplantation [PDF]
Halff, G, Hall, R, Starzl, TE, Todo, S
core +1 more source
Successful Management of Septic Splenitis in an Abyssinian Cat
A 3.5‐year‐old female neutered Abyssinian with pyrexia of unknown origin and splenomegaly was diagnosed with septic splenitis. Complete resolution of clinical signs followed splenectomy and antibiotic treatment with pradofloxacin. Septic splenitis, although uncommon, should be considered as a differential diagnosis in patients with splenomegaly and ...
Martina Vecín Sancho +10 more
wiley +1 more source
Abnormalities of liver sinusoidal endothelial cells in primary biliary cholangitis. [PDF]
Thalassinos E +6 more
europepmc +1 more source
Pediatric liver transplantation. Part II. Diagnostic imaging in postoperative management [PDF]
Bron, KM +6 more
core +1 more source

